Effect of Aclidinium Bromide/Formoterol on Nighttime Lung Function, Respiratory Mechanics and Early Morning Symptoms in Chronic Obstructive Pulmonary Disease (COPD)
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Aclidinium bromide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 09 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 09 Jun 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Nov 2015 Planned End Date changed from 1 May 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.